B. Riley Securities Maintains Buy on Kindly MD, Lowers Price Target to $1
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
B. Riley Securities analyst Fedor Shabalin maintains Kindly MD (NASDAQ:NAKA) with a Buy and lowers the price target from $2 to $1.
B. Riley Securities analyst Fedor Shabalin maintains Kindly MD (NASDAQ:NAKA) with a Buy and lowers the price target from $2 to $1.